ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 15/04/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 22/04/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 29/04/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 06/05/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 13/05/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 20/05/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 27/05/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 03/06/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 10/06/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 17/06/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 24/06/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 01/07/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 08/07/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 15/07/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 22/07/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 29/07/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 05/08/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 12/08/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 19/08/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 26/08/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 02/09/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 09/09/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 16/09/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 23/09/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 30/09/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 07/10/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 14/10/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 21/10/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 28/10/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 04/11/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 18/11/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 25/11/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 02/12/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 09/12/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 16/12/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 23/12/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 30/12/2007

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 06/01/2008

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 13/01/2008

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 20/01/2008

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 27/01/2008

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 03/02/2008

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 10/02/2008

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 17/02/2008

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 24/02/2008

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 02/03/2008

Orphanet database access

Adenylosuccinate lyase deficiency
ORPHANET

Orphanet database access

Adenylosuccinate lyase deficiency


Direct access to data

Summary
Adenylosuccinate lyase deficiency, also called adenylosuccinase deficiency, is an autosomal recessive inherited condition. Adenylosuccinate lyase catalyses the synthesis of purines in two successive steps: the transformation of succinyl aminoimidazole carboxamide ribotide (SAICAR) and the conversion of adenylosuccinate into AMP. Clinical signs are non-specific and include psychomotor retardation, epileptic seizures, and behavioral disorders similar to autism. All of these may be associated with growth retardation and amyotrophy. Diagnosis is made by evidencing SAICAR in plasma, urine, and CSF with a specific technique, and confirmed by high pressure liquid chromatography. Enzymatic deficiency can be demonstrated in leucocytes and fibroblasts. No effective therapy is available. Antenatal diagnosis is feasible* Author: Pr. J.-M. Saudubray (March 2004) *

Update : 09/03/2008

Orphanet database access